• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酒精性肝炎预后评分的比较:一项回顾性研究。

Comparison of prognostic scores for alcoholic hepatitis: a retrospective study.

机构信息

Ivica Grgurević, Department of Gastroenterology, Hepatology, and Clinical Nutrition, Department of Medicine, Dubrava University Hospital, Avenija Gojka Šuška 6, Zagreb 10 000, Croatia,

出版信息

Croat Med J. 2021 Feb 28;62(1):17-24. doi: 10.3325/cmj.2021.62.17.

DOI:10.3325/cmj.2021.62.17
PMID:33660957
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7976889/
Abstract

AIM

To explore the prognostic value of modified Discriminant Function (mDF), Glasgow Alcoholic Hepatitis Score (GAHS), Model of End Stage Liver Disease (MELD), Age-Bilirubin-International Normalized Ratio-Creatinine score (ABIC), and the Lille Model for the 28- and 90-day mortality in patients with alcoholic hepatitis.

METHODS

This retrospective study enrolled patients treated for alcoholic hepatitis in Dubrava University Hospital between January 2014 and May 2018. The diagnosis was established based on histology findings or the combination of patient´s history of ongoing alcohol consumption before hospitalization, serum bilirubin above 50 mmol/L, and aspartate transaminase to alanine transaminase ratio greater than 1.5. We calculated mDF, MELD, GAHS, and ABIC on the first and seventh day of hospitalization (including the Lille model).

RESULTS

In total, 70 patients were enrolled. ABIC at admission most accurately predicted the 28-day mortality, with a cut-off of 9.92 (AUC 0.727; 95% CI 0.608-0.827, P=0.0119), while GAHS most accurately predicted the 90-day mortality, calculated both at admission (cut off >7, AUC 0.765, 95% CI 0.639-0.864, P<0.0001) and after seven days of hospitalization (cut-off >8, AUC 0.835 95% CI 0.716-0.918, P<0.0001). Modified DF was able to predict the 28- and 90-day mortality only when calculated after seven days of hospitalization.

CONCLUSION

There is a need for better prognostic indicators for patients with AH.

摘要

目的

探讨改良判别函数(mDF)、格拉斯哥酒精性肝炎评分(GAHS)、终末期肝病模型(MELD)、年龄-胆红素-国际标准化比值-肌酐评分(ABIC)和利尔模型对酒精性肝炎患者 28 天和 90 天死亡率的预后价值。

方法

本回顾性研究纳入了 2014 年 1 月至 2018 年 5 月在杜布拉瓦大学医院接受酒精性肝炎治疗的患者。诊断依据为组织学检查结果或患者住院前持续饮酒史、血清胆红素>50mmol/L 以及天冬氨酸转氨酶/丙氨酸转氨酶比值>1.5。我们在住院的第 1 天和第 7 天计算了 mDF、MELD、GAHS 和 ABIC(包括利尔模型)。

结果

共纳入 70 例患者。入院时 ABIC 最能准确预测 28 天死亡率,截断值为 9.92(AUC 0.727;95%CI 0.608-0.827,P=0.0119),而 GAHS 最能准确预测 90 天死亡率,无论是入院时(截断值>7,AUC 0.765,95%CI 0.639-0.864,P<0.0001)还是住院第 7 天计算(截断值>8,AUC 0.835 95%CI 0.716-0.918,P<0.0001)。只有在住院第 7 天后计算时,mDF 才能预测 28 天和 90 天的死亡率。

结论

需要更好的预后指标来预测 AH 患者的预后。

相似文献

1
Comparison of prognostic scores for alcoholic hepatitis: a retrospective study.酒精性肝炎预后评分的比较:一项回顾性研究。
Croat Med J. 2021 Feb 28;62(1):17-24. doi: 10.3325/cmj.2021.62.17.
2
Application of prognostic scores in the STOPAH trial: Discriminant function is no longer the optimal scoring system in alcoholic hepatitis.预后评分在 STOPAH 试验中的应用:判别函数不再是酒精性肝炎的最佳评分系统。
J Hepatol. 2018 Mar;68(3):511-518. doi: 10.1016/j.jhep.2017.11.017. Epub 2017 Nov 21.
3
Model of disease severity in alcoholic hepatitis and novel prognostic insights.酒精性肝炎的疾病严重程度模型和新的预后见解。
Rom J Intern Med. 2024 Jan 5;62(2):194-202. doi: 10.2478/rjim-2024-0001. Print 2024 Jun 1.
4
Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis.联合应用肝脏疾病评分系统的数据可更好地预测酒精性肝炎患者的预后。
Gastroenterology. 2015 Aug;149(2):398-406.e8; quiz e16-7. doi: 10.1053/j.gastro.2015.04.044. Epub 2015 Apr 29.
5
The management of alcoholic hepatitis: a prospective comparison of scoring systems.酒精性肝炎的治疗:评分系统的前瞻性比较。
Aliment Pharmacol Ther. 2013 Sep;38(6):603-10. doi: 10.1111/apt.12414. Epub 2013 Jul 23.
6
Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort.酒精性肝炎短期死亡率的九种评分模型:在经活检证实的队列中的交叉验证
Aliment Pharmacol Ther. 2014 Apr;39(7):721-32. doi: 10.1111/apt.12654.
7
Comparison of conventional scoring systems versus MAGIC score to predict short-term mortality in patients hospitalized for alcoholic hepatitis.比较传统评分系统与MAGIC评分在预测酒精性肝炎住院患者短期死亡率方面的差异。
Scand J Gastroenterol. 2020 Nov;55(11):1318-1323. doi: 10.1080/00365521.2020.1822909. Epub 2020 Oct 1.
8
A prognostic evaluation and management of alcoholic hepatitis.酒精性肝炎的预后评估与管理
Minerva Med. 2017 Dec;108(6):554-567. doi: 10.23736/S0026-4806.17.05136-9. Epub 2017 Jun 9.
9
Predicting short-term and long-term mortality of hospitalized Portuguese patients with alcoholic hepatitis.预测葡萄牙住院酒精性肝炎患者的短期和长期死亡率。
Eur J Gastroenterol Hepatol. 2017 Oct;29(10):1141-1148. doi: 10.1097/MEG.0000000000000926.
10
Assessment of scoring systems for acute-on-chronic liver failure at predicting short-term mortality in patients with alcoholic hepatitis.评估急性-on-慢性肝衰竭评分系统对酒精性肝炎患者短期死亡率的预测价值。
World J Gastroenterol. 2016 Nov 7;22(41):9205-9213. doi: 10.3748/wjg.v22.i41.9205.

引用本文的文献

1
Utility of Lille Score in Predicting 30-Day Survival in Steroid-Treated Alcohol-Associated Hepatitis.利尔评分预测激素治疗酒精相关性肝炎 30 天生存率的效用。
Dig Dis Sci. 2024 Aug;69(8):3043-3050. doi: 10.1007/s10620-024-08479-6. Epub 2024 Jun 18.
2
ACG Clinical Guideline: Alcohol-Associated Liver Disease.ACG 临床指南:酒精相关性肝病。
Am J Gastroenterol. 2024 Jan 1;119(1):30-54. doi: 10.14309/ajg.0000000000002572. Epub 2023 Sep 1.
3
Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis.全球酒精相关性肝病的患病率、发病率和结局:系统评价和荟萃分析。
BMC Public Health. 2023 May 11;23(1):859. doi: 10.1186/s12889-023-15749-x.
4
The Impact of Metabolic Syndrome on the Prognosis of High-Risk Alcoholic Hepatitis Patients: Redefining Alcoholic Hepatitis.代谢综合征对高危酒精性肝炎患者预后的影响:重新定义酒精性肝炎
Gastroenterology Res. 2023 Feb;16(1):25-36. doi: 10.14740/gr1556. Epub 2023 Feb 28.
5
Outnumbered: Control Prothrombin Time in Maddrey's Discriminant Function Impacts Steroid Use but Not Mortality in Alcoholic Hepatitis.人数劣势:Maddrey判别函数中控制凝血酶原时间对酒精性肝炎中类固醇使用有影响,但对死亡率无影响。
Biology (Basel). 2022 Dec 16;11(12):1833. doi: 10.3390/biology11121833.

本文引用的文献

1
Alcoholic Hepatitis: A Review.酒精性肝炎:综述。
Alcohol Alcohol. 2019 Jul 1;54(4):408-416. doi: 10.1093/alcalc/agz036.
2
ACG Clinical Guideline for Alcoholic Liver Disease: The MELD Threshold for Corticosteroid Treatment has Yet to be Established.美国胃肠病学会酒精性肝病临床指南:皮质类固醇治疗的终末期肝病模型(MELD)阈值尚未确定。
Am J Gastroenterol. 2019 Jan;114(1):175-176. doi: 10.1038/s41395-018-0076-x.
3
EASL Clinical Practice Guidelines: Management of alcohol-related liver disease.欧洲肝脏研究学会临床实践指南:酒精性肝病的管理
J Hepatol. 2018 Jul;69(1):154-181. doi: 10.1016/j.jhep.2018.03.018. Epub 2018 Apr 5.
4
ACG Clinical Guideline: Alcoholic Liver Disease.ACG 临床指南:酒精性肝病。
Am J Gastroenterol. 2018 Feb;113(2):175-194. doi: 10.1038/ajg.2017.469. Epub 2018 Jan 16.
5
Application of prognostic scores in the STOPAH trial: Discriminant function is no longer the optimal scoring system in alcoholic hepatitis.预后评分在 STOPAH 试验中的应用:判别函数不再是酒精性肝炎的最佳评分系统。
J Hepatol. 2018 Mar;68(3):511-518. doi: 10.1016/j.jhep.2017.11.017. Epub 2017 Nov 21.
6
In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA.在重症酒精性肝炎患者中,泼尼松龙会增加感染易感性和感染相关死亡率,并与循环中细菌DNA的高浓度有关。
Gastroenterology. 2017 Apr;152(5):1068-1077.e4. doi: 10.1053/j.gastro.2016.12.019. Epub 2016 Dec 30.
7
Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia.酒精性肝炎患者临床试验的标准定义和通用数据元素:美国国立酒精滥用与酒精中毒研究所酒精性肝炎联盟的建议
Gastroenterology. 2016 Apr;150(4):785-90. doi: 10.1053/j.gastro.2016.02.042. Epub 2016 Feb 24.
8
Prednisolone or pentoxifylline for alcoholic hepatitis.泼尼松龙或己酮可可碱治疗酒精性肝炎。
N Engl J Med. 2015 Apr 23;372(17):1619-28. doi: 10.1056/NEJMoa1412278.
9
Validation of prognostic scores for clinical use in patients with alcoholic hepatitis.酒精性肝炎患者临床应用预后评分的验证
Scand J Gastroenterol. 2011 Sep;46(9):1127-32. doi: 10.3109/00365521.2011.587200. Epub 2011 May 18.
10
Incidence and mortality of alcoholic hepatitis in Denmark 1999-2008: a nationwide population based cohort study.1999-2008 年丹麦酒精性肝炎的发病率和死亡率:一项全国范围内基于人群的队列研究。
J Hepatol. 2011 Apr;54(4):760-4. doi: 10.1016/j.jhep.2010.07.016. Epub 2010 Sep 19.